Informed-money record

KRYS · Krystal Biotech, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

133

Named actors

Disclosed $ (bull / bear)

$0 / $155.1M

Recent disclosures

25 of 134 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-14	Director (via Goldman Sachs & Co. LLC) Dino A. Rossi	filed notice to sell	$8.3M	SEC ↗
2026-06-25	Officer (via Fidelity Brokerage Services LLC) Thomas John Charles	filed notice to sell	$347K	SEC ↗
2026-06-25	EVP, General Counsel Thomas John Charles	sold	$347K	SEC ↗
2026-06-04	President and CEO Krishnan Krish S	sold	$180K	SEC ↗
2026-06-04	President and CEO Krishnan Krish S	sold	$12K	SEC ↗

109 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals